Wednesday brought a fresh wave of analyst caution as four companies saw their ratings trimmed by Wall Street research shops. Here's what changed and where these stocks stand now.
Truist Securities analyst Anthony Hau pulled back on DigitalBridge Group, Inc. (DBRG), downgrading the investment firm from Buy to Hold while keeping the price target steady at $16. The stock closed Tuesday at $15.28, putting it just below that target line.
Wedbush analyst Matt Bryson had a busy day, downgrading two semiconductor names. He cut GLOBALFOUNDRIES Inc. (GFS) from Outperform to Neutral and trimmed the price target from $42 down to $40. GLOBALFOUNDRIES shares finished Tuesday's session at $36.12, still a decent distance from even the reduced target.
Over at HC Wainwright & Co., analyst Swayampakula Ramakanth downgraded Ekso Bionics Holdings, Inc. (EKSO) from Buy to Neutral. The medical device company's shares closed at $10.58 on Tuesday before the rating change hit.
The headline downgrade came from Bryson's second call of the day. He downgraded Tower Semiconductor Ltd. (TSEM) from Outperform to Neutral, though he kept the price target at $125. Tower Semiconductor shares closed Tuesday at $120.67, suggesting the analyst sees limited upside from current levels even while maintaining a target above the current price.
What's interesting here is the shift from bullish to neutral rather than outright bearish. These analysts aren't necessarily saying run for the hills. They're saying the easy money may have been made, and it's time to reassess whether these stocks still offer compelling upside from here. For Tower Semiconductor in particular, trading just under that $125 target probably explains why the analyst decided neutral made more sense than outperform, even without changing the actual price forecast.
